NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma.

J Hepatol 2006 Jul 7;45(1):81-9. Epub 2006 Feb 7.

Department of Medicine I, Division: Institute of Cancer Research, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria.

Background/aims: In human hepatocellular carcinoma (HCC) the ras-proto-oncogene is rarely mutated. We therefore studied the possible inactivation of the putative tumor-suppressors and ras-associating proteins, NORE1A, NORE1B, and RASSF1A in HCCs by mutation or epigenetic gene silencing through promoter-CpG hypermethylation.

Methods: SSCP-analyses, sequencing, and methylation-specific PCR were performed in 28 fibrotic/cirrhotic livers and 40 HCCs.

Results: The sequence of NORE1A/B exhibited no deviations and that of the RASSF1A gene a non-silent polymorphism ( approximately 10% of cases) and a missense mutation (one HCC). Both alterations may affect the growth-inhibiting capability of RASSF1A. Epigenetic inactivation of NORE1B was found in 62% of the HCCs and in hepatocarcinoma-cell lines due to considerable promoter-methylation of the gene. Methylation was detected also for RASSF1A in HCCs and hepatocarcinoma cell-lines. As a result, 97% of the HCCs revealed epigenetic silencing of NORE1B, RASSF1A, or both. In contrast every third fibrotic/cirrhotic liver only exhibited silencing of one or both genes.

Conclusions: The candidate tumor suppressor genes NORE1B and RASSF1A are epigenetically down-regulated alone in at least 62%, or in combination in 97% of the HCCs studied. This indicates a frequent and critical event in hepatocarcinogenesis, which may allow HCCs to subverse growth-control in the presence of an unaltered Ras.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2005.12.017DOI Listing
July 2006
8 Reads

Publication Analysis

Top Keywords

nore1b rassf1a
12
97% hccs
8
human hepatocellular
8
hepatocellular carcinoma
8
tumor suppressor
8
rassf1a hccs
8
candidate tumor
8
rassf1a
6
hccs
6
nore1b
5
mutation hcc
4
missense mutation
4
cases missense
4
10% cases
4
growth-inhibiting capability
4
affect growth-inhibiting
4
epigenetically down-regulated
4
62% combination
4
down-regulated 62%
4
alterations affect
4

Similar Publications